Curanex Pharmaceuticals Inc Operating Lease Right-of-Use Assets
Curanex Pharmaceuticals Inc (CURX) had Operating Lease Right-of-Use Assets of $280.94 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-14
- 2026-06-30: Operating Lease, Right-of-Use Asset $280.94K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $317.57K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $352.62K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $60.40K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $280.94K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $317.57K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $352.62K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $60.40K 10-Q · filed 2025-11-17 |
| 2025-06-30 | $75.84K 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |